(Source: Business Wire)
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cypress Biosciences (NASDAQ: CYPB), Forest Labs (NYSE: FRX), ArvinMeritor (NYSE: ARM), Apogee Enterprises (NASDAQ: APOG) and The Macerich Company (NYSE: MAC).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Tuesday's Analyst Blog:
Cypress a Top Small Biotech Pick
Cypress Biosciences (NASDAQ: CYPB) announced the approval of Savella for the management of fibromyalgia in January 2009. Along with commercialization partner, Forest Labs (NYSE: FRX), Cypress expects the product to be commercially available around the middle of the year.
We think the approval of Savella is a transformational event for Cypress. We see profitability in 2010 based on a strong ramp in sales. By 2013, we think Cypress can generate revenues in excess of $100 million from royalties and expense reimbursement associated with Savella.
ArvinMeritor Fair at $1 per Share
ArvinMeritor (NYSE: ARM) has a leading position in most of the markets it serves. The company is undergoing dramatic cost reductions through its profit improvement initiative Performance Plus. It is also expanding geographically and outsourcing to low-cost countries.
However, difficult conditions in North American and West European automotive markets are primary concerns for the company. The downturn in the auto industry makes us apprehensive about the near-term prospects for auto suppliers such as ARM. The company has withdrawn its fiscal 2009 financial outlook and suspended the quarterly dividend.
Apogee Hardens Under Pressure
Apogee Enterprises (NASDAQ: APOG), through its subsidiaries, is a leader in technologies for the design and development of value-added glass products, services, and systems.
For the 4th quarter of FY09, Apogee forecasts a decline in revenues and EPS compared to the prior year, as it experiences the first full quarterly impact of the commercial construction slowdown. Also, the company's backlog came under pressure partially due to project delays and cancellations.
Macerich Focuses on Liquidity
Santa Monica, CA-based, The Macerich Company (NYSE: MAC) is a real estate investment trust (REIT) focused on leasing regional and community shopping centers throughout the US.
